US Regulators to Reassess Controversial Peptide with Backing from RFK Jr. Business July 22, 2026 The popularity of peptides—compounds increasingly marketed for promoting sleep, muscle growth, and anti-aging—is on the rise, prompting scrutiny from the…
European Governments Reassess Contracts with Palantir: A Strategic Shift in Defense Technology International June 5, 2026 European governments are increasingly seeking to reduce reliance on U.S.-based Palantir, a major player in data analytics for military applications.…
